Table of Contents

company-logo

Avecho Biotechnology Limited, a biotechnology company, develops, produces, and sells products using its patented platform technology, Targeted Penetration Matrix (TPM) drug delivery system for the pharmaceutical, skin care, animal health, and nutrition industries. It offers TPM and Vital ET products for use in drug delivery and cosmetic formulations; and develops TPM/Oxymorphone and TPM/Oxycodone. The company's human health portfolio covers delivery of pharmaceutical products through gels, injectables, and patches. It also provides non-antibiotic feed additive products to enhance feed efficiency and the health of livestock animals. The company has a collaboration with Lambert Initiative at the University of Sydney to conduct a study to examine whether topically applied cannabidiol can provide relief from symptoms of osteoarthritis. It serves customers in Australia, Switzerland, India, and internationally. The company was formerly known as Phosphagenics Limited and changed its name to Avecho Biotechnology Limited in May 2019. Avecho Biotechnology Limited was incorporated in 1992 and is based in Clayton, Australia.

Avecho Biotechnology Dividend Announcement

• Avecho Biotechnology announced a annually dividend of A$0.02 per ordinary share which will be made payable on 1997-06-06. Ex dividend date: 1997-05-19
• Avecho Biotechnology's trailing twelve-month (TTM) dividend yield is -%

Avecho Biotechnology Dividend History

Ex-Div dateDividend amountDividend typePay date
1997-05-19A$0.02annually1997-06-06
1995-10-25A$0.02annually1995-11-24

Avecho Biotechnology Dividend per year

Avecho Biotechnology Dividend Yield

Avecho Biotechnology current trailing twelve-month (TTM) dividend yield is -%. Interested in purchasing Avecho Biotechnology stock? Use our calculator to estimate your expected dividend yield:

Avecho Biotechnology Financial Ratios

P/E ratio-1.78
PEG ratio-0.02
P/B ratio1.47
ROE-65.78%
Payout ratio0.00%
Current ratio3.54
Quick ratio3.48
Cash Ratio3.04

Avecho Biotechnology Dividend FAQ

Does Avecho Biotechnology stock pay dividends?
Avecho Biotechnology does not currently pay dividends to its shareholders.
Has Avecho Biotechnology ever paid a dividend?
No, Avecho Biotechnology has no a history of paying dividends to its shareholders. Avecho Biotechnology is not known for its dividend payments.
Why doesn't Avecho Biotechnology pay dividends?
There are several potential reasons why Avecho Biotechnology would choose not to pay dividends to their shareholders:

1. Growth opportunities: Companies, especially in fast-growing industries like technology, reinvest earnings into expansion, R&D, or acquisitions to fuel future growth and increase company value.

2. Tax implications: Not paying dividends can reduce the tax burden on shareholders, who may prefer to defer taxes until selling shares and realizing capital gains.

3. Investor preferences: Some investors prefer companies to reinvest profits for higher long-term returns, particularly those seeking capital appreciation over income.

4. Capital allocation priorities: Companies may allocate cash to pay down debt, fund share buybacks, or invest in projects with higher returns than dividends.

5. Market expectations: In certain sectors, like technology, reinvesting profits for growth and innovation is often prioritized over distributing dividends to shareholders.
Will Avecho Biotechnology ever pay a dividend?
The decision for a company to pay dividends depends on various factors including its financial performance, growth prospects, capital allocation priorities, and shareholder preferences. While Avecho Biotechnology has not paid dividends historically and has instead focused on reinvesting its earnings for growth, it's ultimately up to the company's management and board of directors to decide whether to initiate a dividend policy in the future.
Is Avecho Biotechnology a dividend aristocrat?
Avecho Biotechnology is not considered a Dividend Aristocrat. The term "Dividend Aristocrat" is typically used to describe a company in the S&P 500 index that has increased its dividend payouts for at least 25 consecutive years.
Is Avecho Biotechnology a dividend king?
Avecho Biotechnology is not classified as a "Dividend King". A Dividend King is a company that has managed to increase its dividend payouts for 50 consecutive years or more, which is an even more selective group than the Dividend Aristocrats.
Is Avecho Biotechnology a dividend stock?
No, Avecho Biotechnology is not considered a dividend stock. A dividend stock is a stock of a company that regularly pays out dividends to its shareholders.
How to buy Avecho Biotechnology stocks?
To buy Avecho Biotechnology you need a brokerage account. Open an account with a reputable brokerage firm that offers access to the stock market. Consider factors such as fees and account minimums.

Place an order: Use the brokerage's trading platform to place an order to buy Avecho Biotechnology stock.

Remember that buying stocks involves risk, and it's important to carefully consider your investment goals, risk tolerance, and conduct thorough research before making any investment decisions.